Dodge & Cox’s Success and Diversifying Your Bond Portfolio
Funds that favor wide moats, fixed-income performance, and an undervalued biotech name.
Editor's note: We are presenting Morningstar's Investing Insights podcast here. You can subscribe for free on iTunes.
Susan Dziubinski: Hi, I'm Susan Dziubinski from Morningstar.com. At Morningstar, we're fans of wide-moat companies: those companies with durable advantages that should allow them to thrive and keep competitors at bay for a decade or longer. Many money managers like these kinds of companies, too. Here are three highly rated funds focused on wide-moat stocks.